Your search returned 26 results.

Results
	1.	The development of PARP inhibitors in ovarian cancer: from bench to bedside. [electronic resource] by Drew, Yvette Producer: 20160405 In: British journal of cancer vol. 113 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	PARP inhibitors in cancer therapy: two modes of attack on the cancer cell widening the clinical applications. [electronic resource] by Drew, Yvette Plummer, Ruth Producer: 20100218 In: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The potential of PARP inhibitors in genetic breast and ovarian cancers. [electronic resource] by Drew, Yvette Calvert, Hilary Producer: 20081028 In: Annals of the New York Academy of Sciences vol. 1138 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The emerging potential of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer. [electronic resource] by Drew, Yvette Plummer, Ruth Producer: 20100420 In: Current opinion in obstetrics & gynecology vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy. [electronic resource] by Curtin, Nicola J Drew, Yvette Sharma-Saha, Sweta Producer: 20200219 In: Nature reviews. Clinical oncology vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Homologous recombination deficiency and ovarian cancer. [electronic resource] by Ledermann, Jonathan A Drew, Yvette Kristeleit, Rebecca S Producer: 20170703 In: European journal of cancer (Oxford, England : 1990) vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations? [electronic resource] by Bradbury, Alice Hall, Sally Curtin, Nicola Drew, Yvette Producer: 20201211 In: Pharmacology & therapeutics vol. 207 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Emerging treatment options for ovarian cancer: focus on rucaparib. [electronic resource] by Mariappan, Lavanya Jiang, Xue Yan Jackson, Josie Drew, Yvette Publication details: International journal of women's health 2017 In: International journal of women's health vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Targeting the ATR-CHK1 Axis in Cancer Therapy. [electronic resource] by Rundle, Stuart Bradbury, Alice Drew, Yvette Curtin, Nicola J Publication details: Cancers Apr 2017 In: Cancers vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Enteric Type Bartholin Gland Adenocarcinoma: An Unusual Variant of a Rare Neoplasm. [electronic resource] by Robinson, Harry Karpe, Manali Edidi, Ibrahim Fisher, Ann Drew, Yvette Ralte, Angela O'Donnell, Rachel L Producer: 20210830 In: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Evaluating the potential of kinase inhibitors to suppress DNA repair and sensitise ovarian cancer cells to PARP inhibitors. [electronic resource] by Mukhopadhyay, Asima Drew, Yvette Matheson, Elizabeth Salehan, Mo Gentles, Lucy Pachter, Jonathan A Curtin, Nicola J Producer: 20200330 In: Biochemical pharmacology vol. 167 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10. [electronic resource] by Drew, Yvette Kristeleit, Rebecca S Oaknin, Ana Ray-Coquard, Isabelle Haris, Noor Md Swisher, Elizabeth M Producer: 20201208 In: The oncologist vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Exploring the Frequency of Homologous Recombination DNA Repair Dysfunction in Multiple Cancer Types. [electronic resource] by Gentles, Lucy Goranov, Bojidar Matheson, Elizabeth Herriott, Ashleigh Kaufmann, Angelika Hall, Sally Mukhopadhyay, Asima Drew, Yvette Curtin, Nicola J O'Donnell, Rachel L Publication details: Cancers Mar 2019 In: Cancers vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors. [electronic resource] by Mukhopadhyay, Asima Elattar, Ahmed Cerbinskaite, Aiste Wilkinson, Sarah J Drew, Yvette Kyle, Suzanne Los, Gerrit Hostomsky, Zdenek Edmondson, Richard J Curtin, Nicola J Producer: 20100812 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor. [electronic resource] by Franklin, Miriam Gentles, Lucy Matheson, Elizabeth Bown, Nick Cross, Paul Ralte, Angela Gilkes-Immeson, Connor Bradbury, Alice Zanjirband, Maryam Lunec, John Drew, Yvette O'Donnell, Rachel Curtin, Nicola J Producer: 20191114 In: Cancer medicine vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Pharmacokinetic Study of Rucaparib in Patients With Advanced Solid Tumors. [electronic resource] by Shapiro, Geoffrey I Kristeleit, Rebecca S Burris, Howard A LoRusso, Patricia Patel, Manish R Drew, Yvette Giordano, Heidi Maloney, Lara Watkins, Simon Goble, Sandra Jaw-Tsai, Sarah Xiao, Jim J Producer: 20200323 In: Clinical pharmacology in drug development vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2. [electronic resource] by Drew, Yvette Mulligan, Evan A Vong, Wan-Tse Thomas, Huw D Kahn, Samra Kyle, Suzanne Mukhopadhyay, Asima Los, Gerrit Hostomsky, Zdenek Plummer, Elizabeth R Edmondson, Richard J Curtin, Nicola J Producer: 20110328 In: Journal of the National Cancer Institute vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma. [electronic resource] by Daniel, Rachel A Rozanska, Agata L Thomas, Huw D Mulligan, Evan A Drew, Yvette Castelbuono, Deborah J Hostomsky, Zdenek Plummer, E Ruth Boddy, Alan V Tweddle, Deborah A Curtin, Nicola J Clifford, Steven C Producer: 20090330 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. [electronic resource] by Drew, Yvette Ledermann, Jonathan Hall, Geoff Rea, Daniel Glasspool, Ros Highley, Martin Jayson, Gordon Sludden, Julieann Murray, James Jamieson, David Halford, Sarah Acton, Gary Backholer, Zoe Mangano, Raffaella Boddy, Alan Curtin, Nicola Plummer, Ruth Producer: 20160817 In: British journal of cancer vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. [electronic resource] by Drew, Yvette Ledermann, Jonathan Hall, Geoff Rea, Daniel Glasspool, Ros Highley, Martin Jayson, Gordon Sludden, Julieann Murray, James Jamieson, David Halford, Sarah Acton, Gary Backholer, Zoe Mangano, Raffaella Boddy, Alan Curtin, Nicola Plummer, Ruth Publication details: British journal of cancer 06 2016 In: British journal of cancer vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 26 results.